|
You are entering the link to "MetResect" a new educational tool to assist in the management of hepatic metastases in patients due to colorectal cancer. Specifically for the clinical scenario where resection of all disease is contemplated (the patient does not have widely metastatic extrahepatic disease clearly beyond the possibility of resection) and the patient might still attain a long term complete remission, possibly even a "cure".This material was developed by Dr. Neil Love and the staff of Research To Practice (www.ResearchToPractice.com) in collaboration with physicians with special interest and expertise in addressing this clinical situation.MetResect is different than programs such as Adjuvant! because MetResect is primary based on presenting the experience and logic of expert clinicians, rather than attempting a numerical balancing of risks and benefits of therapy. Still MetResect is evidence based, as such expert clinical assessments are based on the medical literature and experience.At this time this tool is open for inspection, evaluation, and comment. It should not yet be used as the sole or predominant source of information used to guide clinical decision making while MetResects undergoes this final additional checking.You can help in this process. Your comments will be much appreciated and can be posted at comments@metresect.net.Clicking the following link will take you into the MetResect.Open MetResect
|
|